Close

Mematon® IC

Mematon® IC

1 tablet contains memantine hydrochloride 10 mg or 20 mg.

In the manifestation of symptoms and the progression of neurodegenerative dementia, an important role is played by the violation of glutamatergic neurotransmission, especially with the participation of N-methyl-D-aspartate (NMDA) receptors.

Memantine is a potentiated, medium affinity noncompetitive antagonist of NMDA receptors. Memantine modulates the effects of a pathologically elevated level of glutamate, which can lead to neuronal dysfunction.

Indications for taking the drug - Alzheimer's disease of moderate to severe forms.

Trade name: MEMATON® ІС
Dosage form: Film coated tablets.
Pharmacotherapeutic group: Psychoanaleptics. Means, used for dementia. Memantine.
ATX Code N06D X01.
Registration number: №UA / 16535/01/01; №UA / 16535/01/02
Date of registration / valid until: the validity period of the registration certificate is not limited from 02.09.2022
Packing: 10 tablets per blister, 3 blisters per pack.
Shelf life: 3 years.
Vacation Category: by prescription.


Full information about this drug you can find in this instruction